Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Studies Say Healthy People Should Take Daily HIV Drug

New guidelines suggest healthy people at risk of HIV should take a daily prevention pill to reduce risk or infection.

Truvada / Image: NBC News
Truvada / Image: NBC News

The United States see almost 40,000 new HIV infections each year, but a new prevention drug stands to drastically decrease that number. According to a recent NBC News article, healthy people at risk of contracting HIV are being advised to take a daily prevention pill called PrEP, or preexposure prophylaxis. Only one brand of the two-medication combo bill has been approved for preventative use in the U.S., and it’s Truvada, made by Gilead Sciences.

PrEP is only recommended for people at high risk of infection, which includes people with HIV-positive sex partners or people who share needles with HIV-positive people. And it does come with a hefty price tag; the average monthly retail cost is almost $2,000.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?